Related Funds
Fund Name | Location |
Carlyle Global Partners | District of Columbia, United States, Washington |
Chilton Investment | Connecticut, Stamford, United States |
Claytonia Capital | California, San Francisco, United States |
Indiana University Health | Indiana, Indianapolis, United States |
Liangshi Investment | China, Gansu, Sichuan |
Paladin Capital Group | District of Columbia, United States, Washington |
Ringier | Switzerland, Zürich, Zurich |
Starta Accelerator | New York, New York, United States |
Yatra Angel Network | India, Maharashtra, Mumbai |
Zhonglu Investment Management | China, Shanghai |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Amber Bio | $26M | 03 Aug 2023 | - | ||
Perceive Biotherapeutics | $78M | 05 Jan 2023 | South San Francisco, California, United States | ||
SparingVision | $88M | 14 Sep 2022 | Paris, Ile-de-France, France | ||
Nacuity Pharmaceuticals | $16M | 15 Jun 2022 | Fort Worth, Texas, United States | ||
SalioGen Therapeutics | $115M | 05 Jan 2022 | Burlington, Massachusetts, United States | ||
Opus Genetics | $19M | 22 Sep 2021 | Raleigh, North Carolina, United States | ||
Vedere Bio | $77M | 18 May 2021 | Cambridge, Massachusetts, United States | ||
Atsena Therapeutics | $55M | 16 Dec 2020 | Durham, North Carolina, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Amber Bio | $26M | 03 Aug 2023 | - | ||
Perceive Biotherapeutics | $78M | 05 Jan 2023 | South San Francisco, California, United States | ||
SparingVision | $88M | 14 Sep 2022 | Paris, Ile-de-France, France | ||
Nacuity Pharmaceuticals | $16M | 15 Jun 2022 | Fort Worth, Texas, United States | ||
SalioGen Therapeutics | $115M | 05 Jan 2022 | Burlington, Massachusetts, United States | ||
Opus Genetics | $19M | 22 Sep 2021 | Raleigh, North Carolina, United States | ||
Vedere Bio | $77M | 18 May 2021 | Cambridge, Massachusetts, United States | ||
Atsena Therapeutics | $55M | 16 Dec 2020 | Durham, North Carolina, United States |